United Natural Foods
UNITED NATURAL FOODS, INC.
Key figures
Period 2025-08-03 to 2026-08-01ConsolidatedU.S. GAAP
RevenueDisclosed
US$31.2B
Operating marginCalculated
0.7%
Net assets to total assetsCalculated
22.8%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
0.7%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
1.9%
Capital efficiency
★★☆☆☆position among all companies
5.2%
Revenue and profit
Performance, financial position and capital allocation
United Natural Foods
Recent performance trends
United Natural Foods
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$28.9 billion | US$30.3 billion | US$31.0 billion | US$31.8 billion | US$31.2 billion |
| Operating income | US$0.4 billion | US$0.1 billion | US$8.00 million | US$-31.00 million | US$0.2 billion |
| Net income | US$0.2 billion | US$24.00 million | US$-0.1 billion | US$-0.1 billion | US$84.00 million |
| Total assets | US$7.6 billion | US$7.4 billion | US$7.5 billion | US$7.6 billion | US$7.1 billion |
| Shareholders' equity | US$1.8 billion | US$1.7 billion | US$1.6 billion | US$1.6 billion | US$1.6 billion |
| Net cash provided by (used in) operating activities | US$0.3 billion | US$0.6 billion | US$0.3 billion | US$0.5 billion | US$0.5 billion |
| Net cash provided by (used in) investing activities | US$-49.00 million | US$-0.3 billion | US$-0.3 billion | US$-0.2 billion | US$-0.2 billion |
| Net cash provided by (used in) financing activities | US$-0.3 billion | US$-0.3 billion | US$92.00 million | US$-0.2 billion | US$-0.4 billion |
| Cash and cash equivalents | US$44.00 million | US$37.00 million | US$40.00 million | US$44.00 million | US$37.00 million |
Revenue scale in the same industry
United Natural Foods
Wholesale (nondurable goods): 16 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 McKESSONFY Mar 2026 US$403.4B
- 2 CencoraFY Sep 2025 US$321.3B
- 3 Cardinal HealthFY Jun 2026 US$254.2B
- … 3 companies
- 7 World KinectFY Dec 2025 US$36.9B
- 8 CHSFY Aug 2025 US$35.5B
- 9 United Natural FoodsThis companyFY Aug 2026 US$31.2B
- 10 Global Partners LPFY Dec 2025 US$18.6B
- 11 AndersonsFY Dec 2025 US$11.0B
- … 5 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.2 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$37.00 million | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.4 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.5 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.3 billion | Consolidated | Disclosed |
| Number of employees | 23,431 | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$1.6 billion | Consolidated | Disclosed |
| Non-controlling interests | US$1.00 million | Consolidated | Disclosed |
| Net assets | US$1.6 billion | Consolidated | Disclosed |
| Net sales | US$31.2 billion | Consolidated | Disclosed |
| Operating income | US$0.2 billion | Consolidated | Disclosed |
| Net income | US$84.00 million | Consolidated | Disclosed |
| Total assets | US$7.1 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$50.00 million | Consolidated | Disclosed |
| Operating margin | 0.7% | Consolidated | Calculated |
| Net assets to total assets | 22.8% | Consolidated | Calculated |
| Net margin | 0.3% | Consolidated | Calculated |
| Return on equity | 5.2% | Consolidated | Calculated |